Home News

ROVI completes the manufacture of the first batches of Moderna vaccine

Laboratorios Farmacéuticos Rovi, S.A. (BME -Spanish Stock Exchanges and Markets: ROVI), a pan-European specialised company engaged in the research, development and marketing of biological specialties and a manufacturer with a high degree of technological

Wed, 13/01/2021 - 17:03 0 min
Download related document
No votes yet
 
Related
ROVI Rating ESG 2020
0 min
25/09/2020
ROVI obtains second place in a global sustainability rating
ROVI obtains second place in a global sustainability rating
ROVI participated voluntarily in this rating, which measures the sustainability of companies based on criteria such as corporate governance...
1 min
25/09/2020
Granting of partially refundable aid for the development of a new quarterly...
0 min
15/09/2020